Reversing resistance to vascular-disrupting agents by blocking late mobilization of circulating endothelial progenitor cells.
Taylor M, Billiot F, Marty V, Rouffiac V, Cohen P, Tournay E, Opolon P, Louache F, Vassal G, Laplace-Builhé C, Vielh P, Soria JC, Farace F.
Taylor M, et al. Among authors: rouffiac v.
Cancer Discov. 2012 May;2(5):434-49. doi: 10.1158/2159-8290.CD-11-0171. Epub 2012 Mar 30.
Cancer Discov. 2012.
PMID: 22588881
Clinical Trial.